COVID-19 vaccine developer CureVac shares more than triple after U.S. debut

West Central Tribune | Willmar

Aug 14, 2020

Aug 14 (Reuters) - Shares of German biotechnology firm CureVac BV soared as much as 222% after their Nasdaq debut on Friday, in the first stock market opening of a company developi…